|

Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among Blacks

RECRUITINGN/ASponsored by University of Miami
Actively Recruiting
PhaseN/A
SponsorUniversity of Miami
Started2024-03-19
Est. completion2027-05-31
Eligibility
Age60 Years – 85 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT06089161

Summary

The purpose of this research is to see how effective the Personalized obstructive sleep apnea (OSA) Treatment Adherence Model called PRAISE is in helping the patient stick to the physician recommended OSA treatment plan Positive Airway Pressure (PAP).

Eligibility

Age: 60 Years – 85 YearsHealthy volunteers accepted
Inclusion Criteria:

* Self-reported race/ethnicity as African American, African, Caribbean or black
* Ages 60-85 years
* accessible by phone
* OSA diagnosis
* consent, including permission to release medical data

Exclusion Criteria:

* progressive illnesses in which disability or death is expected within 1 year
* impaired cognitive/ functional ability precluding participation
* intention to move within the year
* and a family member currently enrolled.

Conditions2

Alzheimer's DiseaseSleep Apnea

Locations1 site

University of Miami
Miami, Florida, 33136
Girardin Jean-Louis, PhD3052430776girardin.jean-louis@miami.edu

Browse More Trials

Alzheimer's Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.